Cystic fibrosis
RecruitingStudy on the Safety and Effects of SPL84 for Patients with Cystic Fibrosis
- Disease:Cystic fibrosis
- Substances:–
Poland- Participants:18–64 years · 65+ years
- Sponsor:Splisense Ltd.
Rare diseases
Investigational molecules
Locations
Back to Poland3 clinical trials in Rabka Zdrój, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on cystic fibrosis treatment are currently underway. The research explores new therapeutic approaches through inhalation-based medication delivery systems.
These trials aim to advance our understanding of respiratory medicine while determining optimal dosing strategies for patients with genetic respiratory conditions.
Research initiatives targeting inherited conditions, specifically genetic respiratory disorders, are making significant progress in therapeutic development.
The studies focus on developing targeted therapies that could potentially improve the quality of life for patients with hereditary respiratory conditions.
Cutting-edge research in pharmaceutical development is underway, examining innovative compounds for respiratory disease management.
These clinical investigations are crucial for advancing treatment options in the field of genetic respiratory disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.